RxNorm 1731345 NDC Crossover

deferoxamine mesylate 2 GM Injection

Related NDC Codes to RxNorm Concept 1731345

The following NDC codes crossover to the RxNorm Concept 1731345. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Status
0409-2337	Deferoxamine Mesylate	Deferoxamine Mesylate	Injection, Powder, Lyophilized, For Solution	Intramuscular; Intravenous; Subcutaneous	Hospira, Inc.	ACTIVE
47781-624	Deferoxamine Mesylate	Deferoxamine Mesylate	Injection, Powder, Lyophilized, For Solution	Intramuscular; Intravenous; Subcutaneous	Alvogen Inc.	ACTIVE
52609-4504	Deferoxamine Mesylate				Apopharma Usa, Inc.	INACTIVATED
52609-4505	Deferoxamine Mesylate				Apopharma Usa, Inc.	INACTIVATED
60505-6236	Deferoxamine Mesylate	Deferoxamine Mesylate	Injection, Powder, Lyophilized, For Solution	Intramuscular; Intravenous; Subcutaneous	Apotex Corp.	ACTIVE
60505-6237	Deferoxamine Mesylate	Deferoxamine Mesylate	Injection, Powder, Lyophilized, For Solution	Intramuscular; Intravenous	Apotex Corp.	ACTIVE
63323-597	Deferoxamine	Deferoxamine Mesylate	Injection, Powder, Lyophilized, For Solution	Intramuscular; Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
63323-599	Deferoxamine	Deferoxamine Mesylate	Injection, Powder, Lyophilized, For Solution	Intramuscular; Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
68083-172	Deferoxamine Mesylate	Deferoxamine Mesylate	Injection, Powder, Lyophilized, For Solution	Intramuscular; Intravenous; Subcutaneous	Gland Pharma Limited	ACTIVE
68083-173	Deferoxamine Mesylate	Deferoxamine Mesylate	Injection, Powder, Lyophilized, For Solution	Intramuscular; Intravenous; Subcutaneous	Gland Pharma Limited	ACTIVE